argenx SE ARGNF
900.30 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
995.00 Day range 995.00
712.03 52-week range 1,020.00
- YTD
- +3.48%
- 1 year
- +14.53%
- Market cap
- 56.62B
- EPS (ttm)
- 28.87
- P/E ratio
- 31.18
- YTD return
- +3.48%
- 1-year return
- +14.53%
- Volume
- 49
- Avg volume
- 7
- Open
- 995.00
- Previous close
- 900.30
- Day's range
- 995.00 – 995.00
- 52-week range
- 712.03 – 1,020.00
1Y +84.87 (+10.41%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 7, 2026 | Dec 31, 2025 | — | 14.38 | — | — |
| Oct 30, 2025 | Jun 30, 2025 | — | 7.33 | — | — |
| May 8, 2025 | Dec 31, 2024 | — | 2.78 | — | — |
| Oct 31, 2024 | Jun 30, 2024 | — | -0.51 | — | — |
| May 9, 2024 | Dec 31, 2023 | — | -3.01 | — | — |
News
argenx: 3 Key Takeaways for Long-Term Investors 
Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium 
BenchSci Announces Two-Year Enterprise Agreement with argenx to Advance AI-Driven Preclinical Drug Discovery 
Argenx to Buy Forte Biosciences for $2.2 Billion 
Argenx to buy Forte Biosciences for about $2.2 billion 
Argenx's Vyvgart sales jump in second quarter 
Sanofi, An Argenx Rival, Bites The Dust — But A Third Biotech Took The Biggest Hit 
argenx SE (ARGX) Q1 2026 Earnings Call Transcript
Your note
Sign in to keep a note on ARGNF — it syncs with the Stock Master app.